Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors
Authors:
- 1 September 2022
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (9) , 949-951
Abstract
This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembroKeywords
This publication has 6 references indexed in Scilit:
- Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitorsJournal for ImmunoTherapy of Cancer, 2021
- Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanismsBrain, 2020
- Central nervous system complications associated with immune checkpoint inhibitorsJournal of Neurology, Neurosurgery & Psychiatry, 2020
- Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumAnnals of Neurology, 2020
- Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung CancerJAMA Oncology, 2019
- Seronegative antibody‐mediated neurology after immune checkpoint inhibitorsAnnals of Clinical and Translational Neurology, 2018